Evidence map›Paper›PMID 38994640›Full record

ArticleBiometrics2024

Absolute risk from double nested case-control designs: cause-specific proportional hazards models with and without augmented estimating equations.

Minjung Lee, Mitchell H Gail

Abstract read
In one paragraph

Article in Biometrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Minjung LeeDepartment of Statistics, Kangwon National University, Chuncheon, Gangwon 24341, South Korea.ORCID 0000-0001-9401-6457
Mitchell H GailBiostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20850, United States.

Funding

Methods for Epidemiology StudiesZ01CP010181 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI CHATTERJEE, NILANJAN · 2003 to 2008
$4.8M
Intramural NIH HHS Z01 CP010181National Research Foundation of Korea NRF-2022R1F1A1065153
6 · The paper itself

Abstract

We estimate relative hazards and absolute risks (or cumulative incidence or crude risk) under cause-specific proportional hazards models for competing risks from double nested case-control (DNCC) data. In the DNCC design, controls are time-matched not only to cases from the cause of primary interest, but also to cases from competing risks (the phase-two sample). Complete covariate data are available in the phase-two sample, but other cohort members only have information on survival outcomes and some covariates. Design-weighted estimators use inverse sampling probabilities computed from Samuelsen-type calculations for DNCC. To take advantage of additional information available on all cohort members, we augment the estimating equations with a term that is unbiased for zero but improves the efficiency of estimates from the cause-specific proportional hazards model. We establish the asymptotic properties of the proposed estimators, including the estimator of absolute risk, and derive consistent variance estimators. We show that augmented design-weighted estimators are more efficient than design-weighted estimators. Through simulations, we show that the proposed asymptotic methods yield nominal operating characteristics in practical sample sizes. We illustrate the methods using prostate cancer mortality data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study of the National Cancer Institute.

Indexed as

Proportional Hazards ModelsProstatic NeoplasmsBiometryCase-Control StudiesComputer SimulationData Interpretation, StatisticalHumansMaleRisk AssessmentRisk Factorsaugmentationcause-specific proportional hazards modelcompeting risksdouble nested case-control designinverse probability weighting

Identifiers

PMID38994640
PMCPMC12010685

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.